FDA approved new medication for chronic weight management
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
On Nov. 8, 2023, the U.S. Food and Drug Administration approved Eli Lilly’s Zepbound (tirzepatide) injection for chronic…
On Jun. 4, 2021, the U.S. Food and Drug Administration announced it had approved Novo Nordisk’s Wegovy (semaglutide)…
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
On Jan. 21, 2021, the National Institutes of Health announced results of a small but highly controlled study…
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…